Lv5
810 积分 2023-06-15 加入
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
2天前
已完结
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
27天前
已完结
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
27天前
已完结
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
1个月前
已完结
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
1个月前
已完结
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
1个月前
已完结
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles
1个月前
已完结
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
1个月前
已完结
Gonadotropin-releasing-hormone-receptor antagonists
1个月前
已完结
The Fertility Cascade: Infertility Prevalence, Access to Treatment and Successful Live Birth
1个月前
已完结
皖公网安备34019202002308
